Nexalin Technology Inc.
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.405
- Today's High:
- $0.4498
- Open Price:
- $0.417
- 52W Low:
- $0.361
- 52W High:
- $2.95
- Prev. Close:
- $0.4
- Volume:
- 21068
Company Statistics
- Market Cap.:
- $2.98 million
- Book Value:
- 0.548
- Revenue TTM:
- $649847
- Operating Margin TTM:
- -410.73%
- Gross Profit TTM:
- $958145
- Profit Margin:
- 0%
- Return on Assets TTM:
- -58.21%
- Return on Equity TTM:
- -277.99%
Company Profile
Nexalin Technology Inc. had its IPO on 2022-09-16 under the ticker symbol NXL.
The company operates in the Healthcare sector and Medical Devices industry. Nexalin Technology Inc. has a staff strength of 6 employees.
Stock update
Shares of Nexalin Technology Inc. opened at $0.42 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.41 - $0.45, and closed at $0.41.
This is a +1.25% increase from the previous day's closing price.
A total volume of 21,068 shares were traded at the close of the day’s session.
In the last one week, shares of Nexalin Technology Inc. have increased by +1%.
Nexalin Technology Inc.'s Key Ratios
Nexalin Technology Inc. has a market cap of $2.98 million, indicating a price to book ratio of 2.5432 and a price to sales ratio of 6.6843.
In the last 12-months Nexalin Technology Inc.’s revenue was $649847 with a gross profit of $958145 and an EBITDA of $-2667210. The EBITDA ratio measures Nexalin Technology Inc.'s overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Nexalin Technology Inc.’s operating margin was -410.73% while its return on assets stood at -58.21% with a return of equity of -277.99%.
In Q2, Nexalin Technology Inc.’s quarterly earnings growth was a positive 0% while revenue growth was a negative 91.4%.
Nexalin Technology Inc.’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-0.31 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Nexalin Technology Inc.’s profitability.
Nexalin Technology Inc. stock is trading at a EV to sales ratio of 6.9358 and a EV to EBITDA ratio of -6.0463. Its price to sales ratio in the trailing 12-months stood at 6.6843.
Nexalin Technology Inc. stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $5.18 million
- Total Liabilities
- $1.18 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $11262
- Dividend Payout Ratio
- 0%
Nexalin Technology Inc. ended 2024 with $5.18 million in total assets and $0 in total liabilities. Its intangible assets were valued at $5.18 million while shareholder equity stood at $3.99 million.
Nexalin Technology Inc. ended 2024 with $0 in deferred long-term liabilities, $1.18 million in other current liabilities, 7287.00 in common stock, $-73960191.00 in retained earnings and $0 in goodwill. Its cash balance stood at $231722.00 and cash and short-term investments were $4.70 million. The company’s total short-term debt was $530,487 while long-term debt stood at $0.
Nexalin Technology Inc.’s total current assets stands at $5.11 million while long-term investments were $0 and short-term investments were $4.46 million. Its net receivables were $14322.00 compared to accounts payable of $48501.00 and inventory worth $160007.00.
In 2024, Nexalin Technology Inc.'s operating cash flow was $0 while its capital expenditure stood at $11262.
Comparatively, Nexalin Technology Inc. paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.41
- 52-Week High
- $2.95
- 52-Week Low
- $0.361
- Analyst Target Price
- $
Nexalin Technology Inc. stock is currently trading at $0.41 per share. It touched a 52-week high of $2.95 and a 52-week low of $2.95. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.67 and 200-day moving average was $0.94 The short ratio stood at 1.18 indicating a short percent outstanding of 0%.
Around 2339.2% of the company’s stock are held by insiders while 79.1% are held by institutions.
Frequently Asked Questions About Nexalin Technology Inc.
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company’s Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. In addition, it designs and develops Generation 2 and Generation 3, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, Alzheimer’s disease, and dementia. The company is based in Houston, Texas.